Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret
Laboratory Medicine · 2025
DOI: 10.1093/labmed/lmae127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2025. Verfasst von Dongyang Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetic Medicine Center, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing, Ch…. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Proto-Oncogene Proteins c-ret. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Nanjing Health Science and Technology Development Special Fund, Clinical frontier technology of Changzhou Health Commission.
Abstract (Originalsprache)
Introduction
Duchenne muscular dystrophy (DMD) is a severe genetic disorder affecting 5% to 19% of carriers. Creatine kinase (CK) is a traditional biomarker for DMD, but its screening accuracy is limited. This study evaluated the potential of combining the proto-oncogene tyrosine-protein kinase receptor Ret (RET) with CK-MM to enhance screening efficacy.
Methods
Creatine kinase-MM and RET levels were analyzed in 14 adult and 5 newborn carriers of DMD, along with noncarrier control individuals. The CK-MM/RET ratio was calculated, and a receiver operating characteristic curve analysis evaluated biomarker screening efficiency. Methods for extracting RET from dried blood spots (DBSs) were compared with correlations between DBSs and serum RET levels and stability under varying storage conditions.
Results
Carriers of DMD exhibited elevated CK-MM and CK-MM/RET ratios with reduced RET. The CK-MM/RET ratio had the highest screening efficiency. Extraction of RET was optimal using Diluent C at 4 °C overnight, showing a strong DBS-serum correlation; RET remained stable, except under high humidity and temperature conditions.
Discussion
Combining RET with CK-MM enhances DMD carrier screening, offering a more efficient DBS-based method for early detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetic Medicine Center, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing, China.
- Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center of Nanjing Medical University, Changzhou, China.
ORCID-Profile: Bin Yu
Förderung
- National Natural Science Foundation of China
- Nanjing Health Science and Technology Development Special Fund
- Clinical frontier technology of Changzhou Health Commission
Zitieren
APA
Hong, D., Zhang, Z., Sun, Y., Wang, X., Yang, P., Jiang, T., & Yu, B. (2025). Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret. Laboratory Medicine. https://doi.org/10.1093/labmed/lmae127
Vancouver
Hong D, Zhang Z, Sun Y, Wang X, Yang P, Jiang T, et al. Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret. Laboratory Medicine. 2025. doi:10.1093/labmed/lmae127
BibTeX
@article{Hong2025,
author = {Hong, Dongyang and Zhang, Zhilei and Sun, Yun and Wang, Xin and Yang, Peiying and Jiang, Tao and Yu, Bin},
title = {Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret},
journal = {Laboratory Medicine},
year = {2025},
doi = {10.1093/labmed/lmae127}
}
EUVIMED